» Articles » PMID: 12217521

The PTEN, Mdm2, P53 Tumor Suppressor-oncoprotein Network

Overview
Specialty Biochemistry
Date 2002 Sep 10
PMID 12217521
Citations 142
Authors
Affiliations
Soon will be listed here.
Abstract

Oncoproteins and tumor-suppressor proteins regulate cell growth and viability. Recent observations show that phosphoinositide 3-kinase (PtdIns 3-kinase)-Akt signaling promotes the phosphorylation and movement of the Mdm2 oncoprotein into the nucleus, where it downregulates the p53 tumor-suppressor protein. The PTEN tumor suppressor protein inhibits activation of Akt and this restricts Mdm2 to the cytoplasm. Restriction of Mdm2 to the cytoplasm promotes p53 function and thereby sustains the sensitivity of cancer cells to chemotherapy. p53 acutely induces Mdm2, providing damaged cells the opportunity for repair, but subsequently induces PTEN, favoring the death of mutated or irrevocably damaged cells. Thus, oncoproteins and tumor suppressor proteins are networked to promote normal cell function and eliminate mutated cells.

Citing Articles

Tumor hypoxia evidences the differential regulation of Mdm2-p53 axis by PTEN in tumor derived vs. normal endothelial cells.

Wilkus-Adamczyk K, Brodaczewska K, Kieda C Sci Rep. 2024; 14(1):31747.

PMID: 39738367 PMC: 11686244. DOI: 10.1038/s41598-024-82638-7.


Aberrant Energy Metabolism in Tumors and Potential Therapeutic Targets.

Fan S, Guo J, Nie H, Xiong H, Xia Y Genes Chromosomes Cancer. 2024; 63(11):e70008.

PMID: 39584783 PMC: 11587691. DOI: 10.1002/gcc.70008.


Comprehensive cataloging of miR-363 as a therapeutic & non-invasive biomarker of prostate cancer.

Manoj A, Ahmad M, Kumar M, Quayoom S, Prasad G, Kumar D Indian J Med Res. 2024; 160(2):236-245.

PMID: 39513205 PMC: 11544578. DOI: 10.25259/ijmr_2274_23.


The Impact of Pdcd4, a Translation Inhibitor, on Drug Resistance.

Wang Q, Yang H Pharmaceuticals (Basel). 2024; 17(10).

PMID: 39459035 PMC: 11510623. DOI: 10.3390/ph17101396.


Regulation of versican expression in macrophages is mediated by canonical type I interferon signaling via ISGF3.

Chang M, Chan C, Brune J, Manicone A, Bomsztyk K, Frevert C Am J Physiol Cell Physiol. 2024; 327(5):C1274-C1288.

PMID: 39400584 PMC: 11559644. DOI: 10.1152/ajpcell.00174.2024.